Biofrontera (BFRI) Other Non-Current Assets (2020 - 2025)
Biofrontera's (BFRI) quarterly Other Non-Current Assets came in at $360000.0 in Q4 2025, down 6.01% year-on-year from $383000.0 in Q4 2024, and down 23.73% quarter-over-quarter from $472000.0 in Q3 2025.
Biofrontera (BFRI) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Biofrontera's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $360000.0 for Q4 2025.
- On a quarterly basis, Other Non-Current Assets fell 6.01% year-over-year to $360000.0 in Q4 2025; TTM through Dec 2025 was $360000.0, a 6.01% decrease from a year earlier, with the FY2025 full-year figure at $360000.0, down 6.01% from the prior year.
- Other Non-Current Assets slipped to $360000.0 in Q4 2025 per BFRI's latest filing, from $472000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.4 million in Q3 2021 and bottomed at $85000.0 in Q3 2022.
- The 5-year median for Other Non-Current Assets is $383000.0 (2024), against an average of $400176.5.
- Across the five-year window, Other Non-Current Assets tumbled 93.81% in 2022 and jumped 478.82% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $268000.0 in 2021, then slumped by 68.28% to $85000.0 in 2022, then soared by 467.06% to $482000.0 in 2023, then fell by 20.54% to $383000.0 in 2024, then fell by 6.01% to $360000.0 in 2025.
- Per Business Quant, the three latest BFRI Other Non-Current Assets figures stand at $360000.0 (Q4 2025), $472000.0 (Q3 2025), and $535000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 360,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 360,000.00 |
| Sep 30, 2025 | 472,000.00 |
| Jun 30, 2025 | 535,000.00 |
| Mar 31, 2025 | 453,000.00 |
| Dec 31, 2024 | 383,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Mar 31, 2024 | 328,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Sep 30, 2023 | 492,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | 85,000.00 |
| Sep 30, 2022 | 85,000.00 |
| Jun 30, 2022 | 128,000.00 |
| Mar 31, 2022 | 268,000.00 |
| Dec 31, 2021 | 268,000.00 |
| Sep 30, 2021 | 1.37 Mn |
| Dec 31, 2020 | 121,000.00 |